Other lipid agents × cardiovascular events

TrialLancet (London, England)2005

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

A Keech et al.PubMed ↗Publisher ↗

What the trial testedas reported · 9,795 people · 2005

Range includes no effect

No clear effect on cardiovascular events

−11%−25% to +5%

10 in 100 instead of 11

Bigger than 2 in 10 for cardiovascular events

As reported

HR 0.89, 95% CI 0.75–1.05

One number in the abstract

the abstract, start to end

reduction of 11%; hazard ratio [HR] 0.89, 95% CI 0.75-1.05; p=0.16).

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
HR 0.890.75–1.05
Other lipid agentsCardiovascular events

Other lipid agents × cardiovascular eventshelps?settled

unlikelylikely
0.800.80 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

949 papers cite itlatest 60 shown

2005
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 16310551